Remedy's New CEO on Unlocking the Commercial Potential of Alan Wake and Control

The Core Problem: "We Haven't Reached Half the Potential"

Gaudechon's diagnosis is blunt and self-aware. He stated that Remedy has "not reached even half the potential" of its intellectual property . The central issue, as he sees it, is not the quality of the games—which receive near-universal acclaim—but a failure of commercial execution. "It's a pity," he said, "I think Alan Wake should have sold more. Control should have sold more. To me, that's one of the first things we need to fix, even before trying to make more games to a certain extent" .

His plan to fix this hinges on three interconnected pillars, with a clear top priority: extract more value from the hits Remedy already has.

1. An IP-First Strategy Over New Game Development

In a notable strategic shift, Gaudechon argued that maximizing the potential of existing franchises like Alan Wake and Control is "in some ways more of a priority" than greenlighting a slate of new titles . He wants to run each franchise as a broader, continuous series rather than treating each entry as a standalone project, focusing on building and expanding player communities over the long term .

2. Cross-Media Expansion with Annapurna

A key vehicle for this growth is Remedy's partnership with Annapurna. Gaudechon sees film and television adaptations as the primary tool to "reach an audience that doesn't exist today" for these games—namely, people who don't play video games at all. The partnership is designed to make the franchises "shine further" and bring them into the broader cultural conversation, driving new players back to the games .

3. Targeting a Far Broader Audience

Underlying these tactics is a philosophical shift toward aggressive audience growth. Gaudechon stated the franchises "need to find audiences that are far larger, much larger" than their current core fanbase . The bottleneck, he has made clear, is not Remedy's famously high creative bar but the studio's historical inability to get its products in front of enough people .

Addressing the EA in the Room: "I Will Not Change the DNA"

Gaudechon did not wait for the question to be asked; he confronted the fandom's anxiety head-on. Acknowledging that many see the appointment of a former EA executive as a move that might "crush Remedy's soul" with big-publisher tactics, he offered a multi-layered defense .

He stated plainly: "I completely understand the concern," and revealed that even his congratulatory messages from industry friends came with the same plea: "Don't screw it up. We love Remedy too much" . His response is a promise that he was chosen precisely because he understands what makes the studio special. "I was chosen because I understand what Remedy is," he explained, emphasizing that he sees his role as triaging what needs to be protected, supported, and grown—not changed .

His central pledge is simple: He will not touch the studio's DNA. He sees his EA background not as a threat but as a toolkit for building a commercial structure strong enough to protect that very creativity. His stated goal is to preserve what makes Remedy unique while fixing only the machinery that connects its products to a global audience .

Remedy's Current Stance on Generative AI

Remedy's position on generative AI was established by interim CEO Markus Mäki prior to Gaudechon's arrival and remains the active corporate policy, as the new CEO has not yet made a public update on the topic.

The official line is one of cautious, ethics-first observation: Remedy is not philosophically opposed to all AI, but it has drawn a hard line against generative AI in its creative process for the present.

• Zero Generative AI in Control Resonant: Mäki confirmed the upcoming game "does not use generative AI content at all" .
• "Varied Interest" Across Teams: There is no company-wide ban. Different crafts and teams within the studio have "varied interest" in investigating AI tools, and the company is monitoring the technology's progression .
• Ethical and Player-Value Guardrails: Remedy's only openness to AI is within strict ethical boundaries. Mäki, a self-described "big believer in player value," said the sole criteria for using any AI tool would be if it "adds player value" and could be deployed ethically, never to replace creative decisions or human artistry .
• A Longer History with Non-Generative AI: In a 2024 financial presentation, CTO Mika Vehkala clarified that Remedy has used "various AI models and techniques" for years in non-generative applications—like procedural tools—but the company is cautious about generative AI tools that could replace creative roles or actors .

For now, as the wider gaming industry wrestles with the rapid proliferation of AI tools, Remedy has positioned itself as a studio where the creative humans are firmly in control. The open question is whether Gaudechon, with his pragmatic commercial focus, will maintain or reshape this policy in the years to come.